Skip to main content
SpringerLink
Log in

Predictive Drug Testing on Human Tumor Cells

  • Book
  • © 1984

Overview

Editors:
  1. Victor Hofmann

    1. Department für Innere Medizin, Abteilung für Onkologie, Universitätsspital Zürich, Zürich, Switzerland

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  2. Michael E. Berens

    1. Department of Obstetrics Gynecology, Bowman Gray, School of Medicine, Winston Salem, USA

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  3. Georg Martz

    1. Department für Innere Medizin, Abteilung für Onkologie, Universitätsspital Zürich, Zürich, Switzerland

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

Part of the book series: Recent Results in Cancer Research (RECENTCANCER, volume 94)

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (30 chapters)

  1. Front Matter

    Pages I-XII
    Download chapter PDF

  2. Clonogenic Assays for Solid Tumors

    1. In Vitro Growth of Human Malignancies in a Cloning Assay

      • M. Rozencweig, V. Hofmann, C Sanders, W. Rombaut, U. Früh, G. Martz
      Pages 1-7

    2. Development and Applications of a Human Tumor Colony Assay for Chemosensitivity Testing

      • S. E. Salmon
      Pages 8-16

    3. A Replenishable Soft Agar Colony Assay for Human Tumour Sensitivity Testing

      • V. D. Courtenay
      Pages 17-34

    4. Analysis of Malignant Effusions by Cellular Composition, Proliferation Kinetics, and In Vitro Clonogenicity

      • V. Hofmann, M. E. Berens, U. Früh
      Pages 35-40

    5. Direct Cloning of Human Ovarian Cancer in Soft Agar: Clinical Limitations and Pharmacologic Applications

      • R. F. Ozols, W. M. Hogan, R. C. Young
      Pages 41-50

    6. Technical Problems with Soft Agar Colony Formation Assays for In Vitro Chemotherapy Sensitivity Testing of Human Solid Tumors: Mayo Clinic Experience

      • M. M. Lieber
      Pages 51-55

    7. Cloning of Human Tumor Cells in Methylcellulose-Containing Medium

      • C. Cillo, N. Odartchenko
      Pages 56-64

    8. The Effect of Chemotherapy on Human Bone Sarcomas: A Clinical and Experimental Study

      • H.-P. Honegger, A. von Hochstetter, P. Groscurth, V. Hofmann, M. Cserhati
      Pages 65-75

  4. Non-Clonogenic Assays for Drug Testing

    1. Development of a Nucleotide Precursor Incorporation Assay for Testing Drug Sensitivity of Human Tumors

      • O. Sanfilippo, M. G. Daidone, N. Zaffaroni, R. Silvestrini
      Pages 127-139

    2. Predictive Relevance for Clinical Outcome of In Vitro Sensitivity Evaluated Through Antimetabolic Assay

      • R. Silvestrini, O. Sanfilippo, M. G. Daidone, N. Zaffaroni
      Pages 140-150

    3. Biochemical Short-Term Predictive Assay: Results of Correlative Trials in Comparison to Other Assays

      • M. Kaufmann
      Pages 151-160

    4. In Vitro Chemosensitivity Assay Based on the Concept of Total Tumor Cell Kill

      • L. M. Weisenthal, R. H. Shoemaker, J. A. Marsden, P. L. Dill, J. A. Baker, E. M. Moran
      Pages 161-173

  5. Evaluation of In Vitro Results

    1. Predictive Tests and Infrequent Events in Cancer Chemotherapy

      • M. Rozencweig, M. Staquet
      Pages 174-183

    2. Pharmacologic Pitfalls in the Human Tumor Clonogenic Assay

      • D. S. Alberts, J. Einspahr, R. Ludwig, S.E. Salmon
      Pages 184-190

    3. Heterogeneity and Variability of Test Results as Limiting Factors for Predictive Assays

      • P. Schlag, D. Flentje
      Pages 191-196
Back to top

Keywords

About this book

Predictive drug testing on human tumor cells in order to define the appropriate chemotherapy will remain imperative as long as the anticancer agents available are few in number and show only limited activity. The advantages of an effective test would lie in obviating the need for testing antineoplastic agents on large cohorts of patients for assessment of drug activity (phase II studies) and in allowing determination of optimal use of anticancer agents (phase III trials). Such an in vitro test could help to better define dose and schedule of drugs preclinically. The additive value of individual drugs could be determined on tumor cells in vitro in order to define the best combination chemotherapy in vivo. Test-directed therapy would avoid unnecessary drug-related morbidity in patients with refractory tumors. Chemotherapy treatment would be more than justified even with side effects if palliation or even prolonged survival could be anticipated as a result. The benefits of predictive drug testing on human tumor cells would extend beyond improvement of individual patient treatment if the testing helped to identify new active agents. This spectrum of benefits to the entire field of oncology pro­ vides tremendous motivation for the development of such testing. Although a number of chemosensitivity tests have been proposed since the advent of modern anticancer chemotherapy, interest has been renewed by the possibility of cloning human tumor cells on agar plates, with a view to testing drug activity on cells with high pro­ liferation capacity.

Editors and Affiliations

  • Department für Innere Medizin, Abteilung für Onkologie, Universitätsspital Zürich, Zürich, Switzerland

    Victor Hofmann, Georg Martz

  • Department of Obstetrics Gynecology, Bowman Gray, School of Medicine, Winston Salem, USA

    Michael E. Berens

Bibliographic Information

  • Book Title: Predictive Drug Testing on Human Tumor Cells

  • Editors: Victor Hofmann, Michael E. Berens, Georg Martz

  • Series Title: Recent Results in Cancer Research

  • DOI: https://doi.org/10.1007/978-3-642-82295-7

  • Publisher: Springer Berlin, Heidelberg

  • eBook Packages: Springer Book Archive

  • Copyright Information: Springer-Verlag Berlin Heidelberg 1984

  • Softcover ISBN: 978-3-642-82297-1Published: 15 December 2011

  • eBook ISBN: 978-3-642-82295-7Published: 06 December 2012

  • Series ISSN: 0080-0015

  • Series E-ISSN: 2197-6767

  • Edition Number: 1

  • Number of Pages: XII, 288

  • Topics: Oncology, Cell Biology, Pharmacology/Toxicology

Publish with us

Policies and ethics

Back to top

Search

Navigation